128 related articles for article (PubMed ID: 32149830)
1. PD-L1 Expression in Extramammary Paget Disease: A Case Series.
Fowler MR; Flanigan KL; Googe PB
Am J Dermatopathol; 2021 Jan; 43(1):21-26. PubMed ID: 32149830
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD3, PD-L1 and CTLA-4 in mammary and extra-mammary Paget disease.
Karpathiou G; Chauleur C; Hathroubi S; Habougit C; Peoc'h M
Cancer Immunol Immunother; 2018 Aug; 67(8):1297-1303. PubMed ID: 29943071
[TBL] [Abstract][Full Text] [Related]
3. Programmed Death-Ligand 1 and Programmed Death-Ligand 2 Expression Can Affect Prognosis in Extramammary Paget's Disease.
Kawaguchi A; Akiba J; Kondo R; Sadashima E; Ogasawara S; Naito Y; Kusano H; Sanada S; Muto I; Nakama T; Yano H
Anticancer Res; 2021 Jan; 41(1):219-226. PubMed ID: 33419816
[TBL] [Abstract][Full Text] [Related]
4. Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy.
Mauzo SH; Tetzlaff MT; Milton DR; Siroy AE; Nagarajan P; Torres-Cabala CA; Ivan D; Curry JL; Hudgens CW; Wargo JA; Sahin AA; Pettaway CA; Prieto VG; Aung PP
Cancers (Basel); 2019 May; 11(6):. PubMed ID: 31146499
[TBL] [Abstract][Full Text] [Related]
5. RANKL expression is a useful marker for differentiation of pagetoid squamous cell carcinoma in situ from extramammary Paget disease.
Fujimura T; Kambayashi Y; Kakizaki A; Furudate S; Aiba S
J Cutan Pathol; 2016 Sep; 43(9):772-5. PubMed ID: 27251225
[TBL] [Abstract][Full Text] [Related]
6. Extramammary Paget disease shows differential expression of B7 family members B7-H3, B7-H4, PD-L1, PD-L2 and cancer/testis antigens NY-ESO-1 and MAGE-A.
Pourmaleki M; Young JH; Socci ND; Chiang S; Edelweiss M; Li Y; Zhang M; Roshal L; Chi DS; Busam KJ; Mellinghoff IK; Hollmann TJ
Oncotarget; 2019 Oct; 10(58):6152-6167. PubMed ID: 31692889
[TBL] [Abstract][Full Text] [Related]
7. Clinical and pathological characteristics of extramammary Paget's disease: report of 246 Chinese male patients.
Kang Z; Zhang Q; Zhang Q; Li X; Hu T; Xu X; Wu Z; Zhang X; Wang H; Xu J; Xu F; Guan M
Int J Clin Exp Pathol; 2015; 8(10):13233-40. PubMed ID: 26722523
[TBL] [Abstract][Full Text] [Related]
8. Characteristic Clinicopathological Features of Secondary Extramammary Paget Disease With Underlying Anorectal Adenocarcinoma: Evenly Circumferential Perianal Distribution, Fibroepithelioma of Pinkus-like Changes, and Subepidermal Mucin Deposits Without Invasive Tumor Cells.
Sasaki Y; Goto K; Sugino T; Satake K; Yoshikawa S; Kiyohara Y
Am J Dermatopathol; 2021 Oct; 43(10):721-726. PubMed ID: 33395042
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of PD-L1 expression and CD8 tumor-infiltrating lymphocytes among subtypes of cutaneous adnexal carcinomas.
Duverger L; Osio A; Cribier B; Mortier L; De Masson A; Basset-Seguin N; Lebbé C; Battistella M
Cancer Immunol Immunother; 2019 Jun; 68(6):951-960. PubMed ID: 30953116
[TBL] [Abstract][Full Text] [Related]
10. Trop2 Expression in Extramammary Paget's Disease and Normal Skin.
Ito T; Tanegashima K; Tanaka Y; Hashimoto H; Murata M; Oda Y; Kaku-Ito Y
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299325
[TBL] [Abstract][Full Text] [Related]
11. Primary invasive extramammary Paget disease on penoscrotum: a clinicopathological analysis of 41 cases.
Shu B; Shen XX; Chen P; Fang XZ; Guo YL; Kong YY
Hum Pathol; 2016 Jan; 47(1):70-7. PubMed ID: 26508372
[TBL] [Abstract][Full Text] [Related]
12. Serum cytokeratin 19 fragment 21-1 and carcinoembryonic antigen combination assay as a biomarker of tumour progression and treatment response in extramammary Paget disease.
Nakamura Y; Tanese K; Hirai I; Amagai M; Kawakami Y; Funakoshi T
Br J Dermatol; 2019 Sep; 181(3):535-543. PubMed ID: 30791097
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease.
Gatalica Z; Vranic S; Krušlin B; Poorman K; Stafford P; Kacerovska D; Senarathne W; Florento E; Contreras E; Leary A; Choi A; In GK
Cancer Med; 2020 Feb; 9(4):1441-1450. PubMed ID: 31899853
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor, androgen-producing enzymes and their transcription factors in extramammary Paget disease.
Azmahani A; Nakamura Y; Ozawa Y; McNamara KM; Fujimura T; Haga T; Hashimoto A; Aiba S; Sasano H
Hum Pathol; 2015 Nov; 46(11):1662-9. PubMed ID: 26359540
[TBL] [Abstract][Full Text] [Related]
15. The utility of p63, CK7, and CAM5.2 staining in differentiating pagetoid intraepidermal carcinomas.
Wieland R; Adhikari P; North J
J Cutan Pathol; 2023 Dec; 50(12):1110-1115. PubMed ID: 37203381
[TBL] [Abstract][Full Text] [Related]
16. Expression of laminin-5 gamma 2 chain predicts invasion of extramammary Paget's disease cell.
Tohmatsu Y; Imura J; Sakai T; Takagi K; Minamisaka T; Tanaka S; Noguchi A; Nakajima T; Nagata T; Makino T; Shimizu T; Fujii T
APMIS; 2021 Jan; 129(1):3-8. PubMed ID: 32996218
[TBL] [Abstract][Full Text] [Related]
17. PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma.
Varki V; Ioffe OB; Bentzen SM; Heath J; Cellini A; Feliciano J; Zandberg DP
Cancer Immunol Immunother; 2018 May; 67(5):805-814. PubMed ID: 29484464
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of TRPS1 in mammary Paget disease, extramammary Paget disease, and their close histopathologic mimics.
Cho WC; Ding Q; Wang WL; Nagarajan P; Curry JL; Torres-Cabala CA; Ivan D; Albarracin CT; Sahin A; Prieto VG; Aung PP
J Cutan Pathol; 2023 May; 50(5):434-440. PubMed ID: 36808637
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of mucin genes in mammary and extramammary Paget's disease.
Kuan SF; Montag AG; Hart J; Krausz T; Recant W
Am J Surg Pathol; 2001 Dec; 25(12):1469-77. PubMed ID: 11717535
[TBL] [Abstract][Full Text] [Related]
20. Multicentric primary extramammary Paget disease: a Toker cell disorder?
Hashemi P; Kao GF; Konia T; Kauffman LC; Tam CC; Sina B
Cutis; 2014 Jul; 94(1):35-8. PubMed ID: 25101342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
